F1I
TSVT

Fund 1 Investments’s 2seventy bio TSVT Stock Holding History

Fund 1 Investments’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-343,504
Closed -$1.01M – 95
2024
Q4 		$1.01M Sell
343,504
-44,912
-12% -$184K 0.09% 51
2024
Q3 		$1.83M Hold
388,416
– – 0.17% 48
2024
Q2 		$1.5M Buy
+388,416
New +$1.75M 0.16% 48

Other funds holding TSVT

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Fund 1 Investments's TSVT Position: Q1 2025 in Review

Fund 1 Investments sold out of 2seventy bio (TSVT) in Q1 2025, closing a stake of 343,504 shares — an estimated $1.01M sold.

Fund 1 Investments first reported a position in TSVT in Q2 2024 and held it in 3 quarters. The position peaked at $1.83M in Q3 2024. 139 funds tracked by Wall St. Rank hold TSVT as of Q1 2025.

  • Fund 1 Investments reported no remaining 2seventy bio position as of Q1 2025 after selling out during the quarter.
  • Fund 1 Investments sold 343,504 2seventy bio shares in Q1 2025, an estimated $1.01M.
  • Fund 1 Investments first reported a position in 2seventy bio in Q2 2024 and held it in 3 quarters.
  • Fund 1 Investments's 2seventy bio position peaked at $1.83M in Q3 2024.
  • 139 funds tracked by Wall St. Rank held 2seventy bio as of Q1 2025.

Based on Fund 1 Investments's 13F filing for Q1 2025, filed 15 May 2025.